Australia markets closed

ClearPoint Neuro, Inc. (CLPT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.20-0.20 (-3.13%)
At close: 04:00PM EDT
6.20 0.00 (0.00%)
Pre-market: 09:05AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,626
-22,089
-16,435
-14,410
-6,782
Depreciation & amortisation
1,660
1,457
777
692
550
Stock-based compensation
6,276
6,079
4,126
2,078
1,090
Change in working capital
-132
-356
-4,289
-1,684
-2,689
Accounts receivable
-774
-1,804
-211
-658
-1,277
Inventory
1,877
1,246
-4,421
-1,714
-25
Other working capital
-12,793
-14,771
-17,313
-12,865
-8,289
Other non-cash items
1
-69
-229
425
893
Net cash provided by operating activities
-11,880
-13,720
-16,167
-12,697
-7,807
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,051
-1,146
-168
-482
Purchases of investments
-
0
-21,590
0
-
Sales/maturities of investments
-
10,000
12,000
0
-
Net cash used for investing activities
9,087
8,949
-10,736
-168
-482
Cash flows from financing activities
Debt repayment
-
-
-
0
-2,838
Common stock issued
-0.001
-
0
46,785
0
Other financing activities
-356
-210
-336
-599
-
Net cash used provided by (used for) financing activities
16,354
296
409
46,875
22,692
Net change in cash
13,561
-4,475
-26,494
34,010
14,403
Cash at beginning of period
21,792
27,615
54,109
20,099
5,696
Cash at end of period
35,353
23,140
27,615
54,109
20,099
Free cash flow
Operating cash flow
-11,880
-13,720
-16,167
-12,697
-7,807
Capital expenditure
-
-1,051
-1,146
-168
-482
Free cash flow
-12,793
-14,771
-17,313
-12,865
-8,289